GB SCIENCES INC
GB Sciences is a plant-based research and biopharmaceutical drug development company. They create patented formulations of plant-inspired, minimum essential mixtures for prescription medications. Their focus includes therapies for Parkinson's Disease and COVID-related Cytokine Release Syndrome. They use their PhAROS AI platform to identify effective combinations of plant-based active ingredients.
Official Registry
AI Quality Analysis
Trust Score Breakdown
Quick Links
Website Highlights
🌟 Similar Trusted Businesses
Kalaris Therapeutics, Inc.
Kalaris is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases. They focus on innovative retinal treatments, including TH103, a potential best-in-class anti-VEGF agent for neovascular AMD. Kalaris aims to ease patient burden and improve outcomes in retinal disease management.
ALX ONCOLOGY HOLDINGS INC
ALX Oncology is a clinical-stage biopharmaceutical company advancing therapies that boost the immune system to treat cancer. Their lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. They focus on developing novel approaches to optimize current and future standards of cancer care.
PUMA BIOTECHNOLOGY, INC.
Puma Biotechnology is a biopharmaceutical company dedicated to the acquisition, development, and commercialization of novel therapeutics for the treatment of cancer. They focus on in-licensing innovative drug candidates that have undergone clinical testing. Puma Biotechnology aims to improve cancer treatment through innovative drug development.